Combining Nivolumab and Ipilimumab with Infliximab or Certolizumab in Patients with Advanced Melanoma: First Results of a Phase Ib Clinical Trial
Anne Montfort(Centre National de la Recherche Scientifique), Nicolás Meyer(Hôpitaux Universitaires de Strasbourg)
Cited by 101
Related Papers
Vismodegib in patients with advanced basal cell carcinoma: Primary analysis of STEVIE, an international, open-label trial
|European Journal of Cancer|2017|284
Vismodegib in patients with advanced basal cell carcinoma (STEVIE): a pre-planned interim analysis of an international, open-label trial
|The Lancet Oncology|2015|244
Risk of lymphoma in patients with atopic dermatitis and the role of topical treatment: A systematic review and meta-analysis
|Journal of the American Academy of Dermatology|2015|204
Randomized Phase III Trial Evaluating Spartalizumab Plus Dabrafenib and Trametinib for BRAF V600–Mutant Unresectable or Metastatic Melanoma
|Zurich Open Repository and Archive (University of Zurich)|2022|146
Efficacy of Immunotherapy in Patients with Metastatic Mucosal or Uveal Melanoma
|Journal of Oncology|2018|82